Metsera, Inc. (MTSR)
NASDAQ: MTSR · Real-Time Price · USD
38.00
+1.50 (4.11%)
Sep 11, 2025, 11:08 AM - Market open
Metsera Employees
As of December 31, 2024, Metsera had 81 total employees, including 74 full-time and 7 part-time employees.
Employees
81
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,800,272
Market Cap
3.99B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MTSR News
- 14 days ago - Metsera to Present at Upcoming September Investor Conferences - GlobeNewsWire
- 6 weeks ago - Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress - GlobeNewsWire
- 3 months ago - Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Metsera Stock Rises As Company Advances Obesity Pipeline With Encouraging Weight Loss Data - Benzinga
- 3 months ago - Metsera rises as experimental weight-loss drug shows promise in small early-stage trial - Reuters
- 3 months ago - Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i - GlobeNewsWire
- 3 months ago - Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association® - GlobeNewsWire
- 4 months ago - Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress - GlobeNewsWire